目的总结无创产前筛查(NIPS)提示6p22.1-p21.32重复高风险孕妇的羊水诊断结果及妊娠结局,为遗传咨询提供依据。
方法收集NIPS提示6p22.1-p21.32重复高风险孕妇的临床信息、羊水诊断结果和妊娠结局,并对相关数据进行分析。本研究通过了郑州大学第一附属医院医学伦理委员会的审查(批准号:2018-YB-08)。
结果共发现43例高风险孕妇,其中30人接受了羊水诊断,27例证实为假阳性,3例胎儿均存在其他染色体异常,其中2例判定为可能良性变异,1例为致病性变异。35例胎儿出生正常,1例终止妊娠,7例失访。
结论对于NIPS提示6p22.1-p21.32重复高风险的孕妇,应做好遗传咨询,告知其假阳性率高,在尽量减轻心理和经济负担的前提下,建议其接受羊水诊断并定期孕检。
ObjectiveTo summarize the results of prenatal diagnosis and outcome of pregnancy of fetuses with a high risk for 6p22.1-p21.32 duplication signaled by non-invasive prenatal screening (NIPS).
MethodsClinical information, results of prenatal diagnosis and pregnancy for fetuses with a high risk for 6p22.1-p21.32 duplication were collected and analyzed. This study has been approved by the medical Ethics Committee of the First Affiliated Hospital of Zhengzhou University (Ethic No.2018-YB-08).
ResultsForty three pregnant women with a high risk for 6p22.1-p21.32 duplication were identified by NIPS, among whom 30 had accepted invasive prenatal diagnosis, and 27 fetuses were verified to be false positive. Three fetuses were found to have other chromosomal abnormalities, among whom two were rated to be likely benign CNV and 1 was rated to be likely pathogenic. Follow up of the 43 pregnant women revealed that 35 fetuses were normal after birth, 1 pregnancy was terminated, and 7 were lost to follow up.
ConclusionFor pregnant women with a high risk for 6p22.1-p21.32 duplication signaled by NIPS, genetic counselor need to inform them the high false positive rate and recommend invasive prenatal diagnosis and/or ultrasound examination in order to reduce the psychological and economic burdens.
代鹏,赵干业,侯雅勤,等. 无创产前筛查提示胎儿6p22.1-p21.32重复的产前诊断及临床结局分析[J]. 中华医学遗传学杂志,2024,41(12):1411-1415.
DOI:10.3760/cma.j.cn511374-20240703-00368版权归中华医学会所有。
未经授权,不得转载、摘编本刊文章,不得使用本刊的版式设计。
除非特别声明,本刊刊出的所有文章不代表中华医学会和本刊编委会的观点。
代鹏:实施研究、起草文章、采集数据、分析/解释数据和统计分析;赵干业:采集数据、分析/解释数据和统计分析、对文章的内容作批评性审阅;侯雅勤:分析数据、对文章的内容作批评性审阅;胡爽:对文章的内容作批评性审阅;孔祥东:对文章的内容作批评性审阅、指导研究、行政、技术或材料支持、支持性贡献

你好,我可以帮助您更好的了解本文,请向我提问您关注的问题。